1h Free Analyst Time
The ai in oncology market is forecasted to grow by USD 7.54 billion during 2024-2029, accelerating at a CAGR of 27.8% during the forecast period. The report on the ai in oncology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing volume and complexity of oncological data, growing demand for personalized medicine and precision oncology, and accelerating technological advancements in ai and computational infrastructure.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The ai in oncology market is segmented as below:
By Component
- Software solutions
- Services
By Type
- Breast cancer
- Lung cancer
- Kidney cancer
- Others
By Application
- Diagnosis
- Drug discovery and development
- Treatment planning
- Prognosis prediction
By Geographical Landscape
- North America
- Europe
- APAC
- South America
- Middle East and Africa
The report on the ai in oncology market covers the following areas:
- AI In Oncology Market sizing
- AI In Oncology Market forecast
- AI In Oncology Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Five Forces Analysis
7 Market Segmentation by Component
8 Market Segmentation by Type
9 Market Segmentation by Application
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global ai in oncology market: BenevolentAI, ConcertAI, Inc., F. Hoffmann La Roche Ltd., Freenome Holdings Inc., GE Healthcare Technologies Inc., Google LLC, International Business Machines Corp., Koninklijke Philips NV, Lunit Inc., Microsoft Corp., NVIDIA Corp., Owkin Inc., PAIGE LLC, PathAI Inc., Recursion Pharmaceuticals Inc., Siemens Healthineers AG, SOPHiA GENETICS, and Tempus Labs Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rise of multimodal ai and integrated diagnostics."
According to the report, one of the major drivers for this market is the increasing volume and complexity of oncological data.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- BenevolentAI
- ConcertAI Inc.
- F. Hoffmann La Roche Ltd.
- Freenome Holdings Inc.
- GE Healthcare Technologies Inc.
- Google LLC
- International Business Machines Corp.
- Koninklijke Philips NV
- Lunit Inc.
- Microsoft Corp.
- NVIDIA Corp.
- Owkin Inc.
- PAIGE LLC
- PathAI Inc.
- Recursion Pharmaceuticals Inc.
- Siemens Healthineers AG
- SOPHiA GENETICS
- Tempus Labs Inc.
